The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors

BACKGROUND: Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) have been widely used in treating different malignancies. Several studies have reported that the gut microbiota modulates the response and adverse events (AEs) to ICIs in melanoma, non–small cell lung ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhaozhen, Zhang, Sujie, Li, Lingling, Huang, Ziwei, Huang, Di, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641019/
https://www.ncbi.nlm.nih.gov/pubmed/36387171
http://dx.doi.org/10.3389/fonc.2022.887383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641019/
https://www.ncbi.nlm.nih.gov/pubmed/36387171
http://dx.doi.org/10.3389/fonc.2022.887383

Ejemplares similares